Condition 1: Diabetes. Condition 2: Diabetic nephropathy. Diabetes mellitus due to underlying condition with kidney complications Diabetes mellitus due to underlying condition with diabetic nephropathy
Conditions
Interventions
Intervention 1: Control group: Diabetic diet based on approved guideline of american diabetes association (1500-1800 calorie, 55–65% carbohydrate, =30% fat, and 10–20% protein) plus 3 placebo capsule
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Diabetes diagnosis by a specialist physician (based on criteria of the American Diabetes Association) Diagnosis of nephropathy by a specialist physician (based on criteria of the American Diabetes Association), patient with a minimum GFR equal to or greater than 30 mL / min / 1.73 m2 and in microalbuminuria (299-30 mg / g Cr) or macroalbuminuria (mg / g Cr) 300=) No use of alcohol and tobacco Constant weight during the last 6 months (self-report) The constancy of the type and dose of drugs in the past 6 months (self-report)
Exclusion criteria
Exclusion criteria: Occurrence of acute heart disease, stroke, liver or gastrointestinal diseases, thyroid and parathyroid disease, rheumatoid arthritis and infectious Pregnancy or lactation Using any dietary supplement in the past 6 months (self-report)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urine microalbumin. Timepoint: At start and after 10 weeks of intervention. Method of measurement: Biochemical (with special kits made by BIOREX company by immunoturbidometric method).;Estimated glomerular filtration rate. Timepoint: Before intervention and 10 weeks after intervention. Method of measurement: The CKD-EPI Creatinine Equation for Glomerular Filtration Rate. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArash Dashtabi
Shiraz University of Medical Sciences
Outcome results
None listed